Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preventing cholestasis in premature infants using SMOFlipid
2011-005456-33Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Jan 2012
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of SMOFlipid, Intralipid 10% in parenteral nutrition-associated cholestasis (PNAC), sponsored by Medical University of Vienna. Started Jan 2012; status: completed.
02
Drugs
SMOFlipidIntralipid 10%
03
Conditions
parenteral nutrition-associated cholestasis (PNAC)
Beyond the preview
Go deeper on 2011-005456-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005456-33.